Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2004 1
2005 1
2006 2
2007 1
2008 3
2009 1
2011 2
2012 4
2013 3
2014 2
2015 2
2019 1
2020 1
2021 1
2022 1
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
Aronson SL, Lopez-Yurda M, Koole SN, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van Gent MDJM, Arts HJG, van Ham MAPC, van Dam PA, Vuylsteke P, Aalbers AGJ, Verwaal VJ, Van de Vijver KK, Aaronson NK, Sonke GS, van Driel WJ. Aronson SL, et al. Among authors: van ham mapc. Lancet Oncol. 2023 Oct;24(10):1109-1118. doi: 10.1016/S1470-2045(23)00396-0. Epub 2023 Sep 11. Lancet Oncol. 2023. PMID: 37708912 Clinical Trial.
Clinical management of uterine papillary serous carcinoma.
Roelofsen T, van Ham MA, de Hullu JA, Massuger LF. Roelofsen T, et al. Among authors: van ham ma. Expert Rev Anticancer Ther. 2011 Jan;11(1):71-81. doi: 10.1586/era.10.199. Expert Rev Anticancer Ther. 2011. PMID: 21166512 Review.
[Familial history of ovarian carcinoma: policy].
de Hullu JA, Kets CM, Massuger LF, Ligtenberg ML, van Ham MA, Hoogerbrugge N. de Hullu JA, et al. Among authors: van ham ma. Ned Tijdschr Geneeskd. 2011;155:A2392. Ned Tijdschr Geneeskd. 2011. PMID: 21262027 Review. Dutch.
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide.
Baldewpersad Tewarie N, van Driel WJ, van Ham MAPC, Wouters MW, Rome RM, Høgdall CK, Pagano E, Hogberg T, Kruitwagen R; participants of the - Dutch Gynecological Oncology Group. Baldewpersad Tewarie N, et al. Among authors: van ham mapc. Eur J Surg Oncol. 2022 Oct;48(10):2094-2103. doi: 10.1016/j.ejso.2022.06.020. Epub 2022 Jun 23. Eur J Surg Oncol. 2022. PMID: 35931589 Free article. Review.
Histopathologic assessment of the entire endometrium in asymptomatic women.
Mingels MJ, Geels YP, Pijnenborg JM, van der Wurff AA, van Tilborg AA, van Ham MA, Massuger LF, Bulten J. Mingels MJ, et al. Among authors: van ham ma. Hum Pathol. 2013 Oct;44(10):2293-301. doi: 10.1016/j.humpath.2013.05.011. Epub 2013 Aug 9. Hum Pathol. 2013. PMID: 23938162
Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer.
Koole SN, Kieffer JM, K Sikorska, Schagen van Leeuwen JH, Schreuder HWR, Hermans RH, de Hingh IH, van der Velden J, Arts HJ, van Ham MAPC, Aalbers AG, Verwaal VJ, Van de Vijver KK, Sonke GS, van Driel WJ, Aaronson NK. Koole SN, et al. Among authors: van ham mapc. Eur J Surg Oncol. 2021 Jan;47(1):101-107. doi: 10.1016/j.ejso.2019.05.006. Epub 2019 May 13. Eur J Surg Oncol. 2021. PMID: 31128948 Clinical Trial.
Case-mix adjustment to compare hospital performances regarding complications after cytoreductive surgery for ovarian cancer: a nationwide population-based study.
Algera MD, Baldewpersad Tewarie NMS, Driel WJV, van Ham MAPC, Slangen BFM, Kruitwagen RFPM, Wouters MWJM; Participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Among authors: van ham mapc. Int J Gynecol Cancer. 2023 Apr 3;33(4):534-542. doi: 10.1136/ijgc-2022-003981. Int J Gynecol Cancer. 2023. PMID: 36581486
29 results